Measurement of Aldosterone in Human Plasma by Semiautomated HPLC-Tandem Mass Spectrometry

被引:103
|
作者
Taylor, Paul J. [1 ,2 ,3 ]
Cooper, Donald P. [4 ]
Gordon, Richard D. [2 ,3 ]
Stowasser, Michael [2 ,3 ]
机构
[1] Princess Alexandra Hosp, Dept Clin Pharmacol, Brisbane, Qld 4102, Australia
[2] Univ Queensland, Greenslopes Hosp, Endocrine Hypertens Res Ctr, Brisbane, Qld, Australia
[3] Univ Queensland, Princess Alexandra Hosp, Endocrine Hypertens Res Ctr, Brisbane, Qld, Australia
[4] Waters Corp, Manchester, Lancs, England
关键词
CHROMATOGRAPHY; RADIOIMMUNOASSAY; SERUM; IMMUNOASSAY; DIAGNOSIS; KIT;
D O I
10.1373/clinchem.2008.116004
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: Reliable measurement of aldosterone with less interlaboratory variation than RIA would help standardize testing for primary aldosteronism. We set out to validate a high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method for aldosterone in human plasma. METHODS: We prepared samples (EDTA plasma, lithium heparin plasma, and serum from separator and plain clot tubes) and measured aldosterone using online HPLC-MS/MS with d(7)-aldosterone as internal standard. We also analyzed EDTA plasma samples by immunoassay. We established a reference range for HPLC-MS/MS aldosterone by analyzing blood collected midmorning from 97 normotensive seated subjects. RESULTS: The linear range was 69.4-5548.0 pmol/L (2.5-200 ng/dL) (r(2) > 0.994, n = 14). Inter- and intraday analytical recovery and imprecision for quality control samples of 166.4, 1109.6, and 4161.0 pmol/L (6.0, 40.0, and 150.0 ng/dL) were 92.2%-102.0% and <6.3%, respectively (n = 5). The lower limit of quantification was 69.4 pmol/L (2.5 ng/dL), with inter- and intraday analytical recovery and imprecision of 91.4%-94.5% and <9.5% (n = 5). No interferences were observed in plasma from Addison's disease patients (n = 5). Comparison of collection tubes, using EDTA as the reference, revealed similar aldosterone results. Comparison of HPLC-MS/MS with immunoassay gave an acceptable mean bias (0.83%) but wide range (-44.8% to 39.7%) of differences. HPLC-MS/MS aldosterone concentrations in normotensive subjects ranged from <69.4 to 635.2 pmol/L (<2.5 to 22.9 ng/dL). CONCLUSIONS: This first reported aldosterone method using online HPLC-MS/MS is precise across the clinically relevant range, not influenced by collection tube type, and offers semiautomated sample preparation and high throughput. (C) 2009 American Association for Clinical Chemistry,
引用
收藏
页码:1155 / 1162
页数:8
相关论文
共 50 条
  • [1] Simultaneous Measurement of Aldosterone and Cortisol in Plasma by HPLC-Tandem Mass Spectrometry: Application to Sports Medicine Studies
    Taylor, Paul J.
    van Rosendal, Simon
    Coombes, Jeff S.
    Gordon, Richard
    Stowasser, Michael
    [J]. THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 640 - 641
  • [2] Measurement of Oxypurinol Concentrations in Urine by HPLC-Tandem Mass Spectrometry
    Franklin, Michael E.
    Anderson, Jacqueline M.
    Stocker, Sophie L.
    Pillans, Peter I.
    Williams, Ken M.
    Day, Richard O.
    Taylor, Paul J.
    [J]. THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 640 - 640
  • [3] The measurement of flumazenil in rat blood by HPLC-tandem mass spectrometry
    Franklin, Michael E.
    Myers, Damian E.
    Dedeurwaerdere, Stefanie
    Vivash, Lucy
    Taylor, Paul J.
    [J]. THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 470 - 470
  • [4] Measurement of serum steroid profiles by HPLC-tandem mass spectrometry
    Olisov, Dmitrii
    Lee, Kyunghoon
    Jun, Sun-Hee
    Song, Sang Hoon
    Kim, Jae Hyun
    Lee, Young Ah
    Shin, Choong Ho
    Song, Junghan
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2019, 1117 : 1 - 9
  • [5] Measurement of Aldosterone and Cortisol by HPLC-Tandem Mass Spectrometry: Could This Improve Decision Making in Primary Aldosteronism?
    Taylor, Paul J.
    Gordon, Richard D.
    Stowasser, Michael
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2012, 25 (12) : 1319 - 1319
  • [6] The measurement of total and free mycophenolic acid by HPLC-tandem mass spectrometry
    Franklin, Michael E.
    Brown, Nigel W.
    Walters, Margaret
    Tredger, J. Michael
    Salm, Paul
    Pillans, Peter I.
    Taylor, Paul J.
    [J]. THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 525 - 526
  • [7] Determination of 5-fluorouracil in plasma with HPLC-tandem mass spectrometry
    van Kuilenburg, A. B. P.
    van Lenthe, H.
    Maring, J. G.
    van Gennip, A. H.
    [J]. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2006, 25 (9-11): : 1257 - 1260
  • [8] Determination of thymine, dihydrothymine and ureidoisobutyrate in human plasma, saliva and urine using HPLC-tandem mass spectrometry
    Ni, M.
    Duley, J. A.
    George, R.
    Charles, B. G.
    Norris, R. L. G.
    [J]. THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 490 - 490
  • [9] Identification of compounds in wine by HPLC-tandem mass spectrometry
    Bevilacqua, L
    Buiarelli, F
    Coccioli, F
    Jasionowska, R
    [J]. ANNALI DI CHIMICA, 2004, 94 (9-10) : 679 - 689
  • [10] Method development and validation of ursodiol and its major metabolites in human plasma by HPLC-tandem mass spectrometry
    Pinto, Marcio Cardoso
    Berton, Danilo Chorfi
    de Oliveira, Alexandre Cavenatti
    Lazaro, Carolina Martins
    Calafatti Carandina, Silvana Aparecida
    [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2019, 11 : 1 - 13